SERPING1 and hepatocellular carcinoma: Moreover, sorafenib‐mediated SERPING1 upregulation was also observed in the conditioned medium of HepG2 cells, suggesting that SERPING1 might be a marker for sorafenib sensitivity in HCC (Figure 2F).